期刊
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
卷 41, 期 4, 页码 311-317出版社
ELSEVIER
DOI: 10.1016/j.ijantimicag.2012.12.007
关键词
Malaria; Artemisinin; Drug resistance; Plasmodium falciparum
资金
- Princeton University (Harold W. Dodds Fellowship)
- Models of Infectious Disease Agent Study (MIDAS) from the National Institutes of General Medical Sciences [U01GM070708]
The emergence of resistance to former first-line antimalarial drugs has been an unmitigated disaster. In recent years, artemisinin class drugs have become standard and they are considered an essential tool for helping to eradicate the disease. However, their ability to reduce morbidity and mortality and to slow transmission requires the maintenance of effectiveness. Recently, an artemisinin delayed-clearance phenotype was described. This is believed to be the precursor to resistance and threatens local elimination and global eradication plans. Understanding how resistance emerges and spreads is important for developing strategies to contain its spread. Resistance is the result of two processes: (i) drug selection of resistant parasites; and (ii) the spread of resistance. In this review, we examine the factors that lead to both drug selection and the spread of resistance. We then examine strategies for controlling the spread of resistance, pointing out the complexities and deficiencies in predicting how resistance will spread. (C) 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据